Jeffrey B. Mirviss serves as the Executive Vice President and President of Peripheral Interventions at Boston Scientific Corporation, a leading innovator in medical solutions. In his current role, Mirviss is responsible for overseeing the strategic direction and operational performance of the Peripheral Interventions division, which focuses on developing and commercializing innovative medical devices for the treatment of peripheral vascular disease. His leadership has been instrumental in driving growth and advancing the company's mission to improve patient outcomes through cutting-edge technology. Prior to his current position, Mirviss held various leadership roles within Boston Scientific, demonstrating his commitment to the company's success and his deep understanding of the medical device industry. With over two decades of experience in the healthcare sector, he has a proven track record of driving innovation, fostering collaboration, and delivering results. Mirviss's strategic vision and ability to navigate complex market dynamics have been key factors in the Peripheral Interventions division's continued success and growth. Under Mirviss's leadership, the Peripheral Interventions division has introduced several groundbreaking products that have revolutionized the treatment of peripheral vascular disease. His focus on patient-centric innovation and his dedication to improving the lives of those affected by these conditions have earned him respect and admiration within the industry. As a member of Boston Scientific's executive leadership team, Mirviss continues to play a vital role in shaping the company's future and solidifying its position as a leader in the medical device market.